Cargando…
Abatacept in rheumatoid arthritis-associated interstitial lung disease: short-term outcomes and predictors of progression
INTRODUCTION: Interstitial lung disease in rheumatoid arthritis (RA-ILD) is an extra-articular involvement that impairs the prognosis and for which there is still no well-coded treatment. The aim of this study was to evaluate abatacept (ABA) effectiveness and safety in patients with RA-ILD. METHODS:...
Autores principales: | Tardella, Marika, Di Carlo, Marco, Carotti, Marina, Giovagnoni, Andrea, Salaffi, Fausto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599404/ https://www.ncbi.nlm.nih.gov/pubmed/34313866 http://dx.doi.org/10.1007/s10067-021-05854-w |
Ejemplares similares
-
A retrospective study of the efficacy of JAK inhibitors or abatacept on rheumatoid arthritis-interstitial lung disease
por: Tardella, Marika, et al.
Publicado: (2022) -
High-resolution computed tomography of the lung in patients with rheumatoid arthritis: Prevalence of interstitial lung disease involvement and determinants of abnormalities
por: Salaffi, Fausto, et al.
Publicado: (2019) -
Ultrasound B-lines in the evaluation of interstitial lung disease in patients with systemic sclerosis: Cut-off point definition for the presence of significant pulmonary fibrosis
por: Tardella, Marika, et al.
Publicado: (2018) -
Early response to JAK inhibitors on central sensitization and pain catastrophizing in patients with active rheumatoid arthritis
por: Salaffi, Fausto, et al.
Publicado: (2022) -
The value of ultrasound and magnetic resonance imaging scoring systems in explaining handgrip strength and functional impairment in rheumatoid arthritis patients: a pilot study
por: Salaffi, Fausto, et al.
Publicado: (2022)